E-mail:gzliang@cqu.edu.cn    Tel: (86)2365102507

List of peptide properties
DFBP ID - DFBPOPIO0011(Opioid peptide)
DFBP ID DFBPOPIO0011
Peptide sequence YPFPGPI
Type Native peptide
Peptide/Function name Opioid peptide, β-Casomorphin-7
Function-activity relationship
Main bioactivity Opioid activity
Otheir bioactivity ACE-inhibitory activity [D1], Antithrombotic activity [D2], Multifunctional activity [D3]
Calculated physicochemical properties
Three-letter amino acid Tyr-Pro-Phe-Pro-Gly-Pro-Ile
Single-letter amino acid YPFPGPI
Peptide length 7
Peptide mass
Experimental mass Theoretical mass
N.D 789.92 Da c
Net charge 0.00 c
Isoelectric point (pI) 5.92 c
IC50 N.D
pIC50 N.D
GRAVY 0.1143 c
Hydrophilic residue ratio 85.71% c
Peptide calculator
To calculate the physicochemical properties of bioactive peptide.
Peptide source & Food-borne protein(s) search
Classification Animal
Organism/Source Cheese (Cheddar, Swiss, Brie, Limburger, Blue), Bovine milk protein [2,3]
Precursor protein β-Casein
Residue position f(60-66)
Precursor protein(s) search
Link-research
There are no literature reports on the discovery of this sequence in other food-source proteins.
Biological/Functional activity & target protein
Opioid activity The heptapeptide YPFPGPI showed potently opioid activity for μ-opiate receptor. After carboxypeptidase digestion a pentapeptide, YPFPG, could be isolated; this peptide showed a higher opioid activity than the heptapeptide. As shown in table 1.
Table 1 Opioid activity of peptides
Peptide
IC50 (uM)
IC50 MVD
Activity
References
RAa
GPIb
MVDc
IC50 GPI
YPFPGPI55
> 500
Opioid agonist
This peptide showed potently active as opioid agonist (IC50 = 14.0 umol/l) and has been characterized as μ-type ligands
[2]
306.9
nd[3]
Opioid peptides are opioid μ-receptor ligands (Receptor affinity IC50 = 3.6 μM) with agonistic activities (Opioid activity in GPI assay IC50 = 3.2 μM).[14]
a Radioreceptor assay in the presence of 1 nM [3H]naloxone.
b Guinea pig ileum assay.
c Mouse vas deferens assay. nd, not determined.
Specific target protein(s) Specific Target Protein(s):
Mu-type opioid receptor
Taste properties & Structure
Bitterness
Literature report Bitter peptide according to BIOPEP database of sensory peptides and amino acids [D4].
Bitter prediction tools Bitter taste prediction
SMILES N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N1[C@@]([H])(CCC1)C(=O)NCC(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)O
Preparation method
Mode of preparation Enzymatic hydrolysis
Enzyme(s)/starter culture

(1) Hydrolysis with Pepsin.
(2) To simulate in vivo digestion, bovine β-casein was digested by pepsin, pancreatin and then by leucine aminopeptidase (LAP) [14].

Stability & Cytotoxicity
Peptide stability
Literature report:

The opioid peptide was highly resistant towards proteolysis, even by pronase.

EHP-Tool: Enzymatic Hydrolysis Prediction Tool (EHP-Tool)
Peptide cytotoxicity
Literature report: N.D
Prediction: ToxinPred
Additional information
Additional information

The sequence of bovine β-casein (59-81) is -LVYPFPGPI-Pro67/His67-NSLPQNIPPLTQTP- [14].

Database cross-references
DFBP
[D1] DFBPACEI0345
[D2] DFBPANTH0169
[D3] DFBPMUFU0103
BIOPEP-UWM [D4] 3262, 7665
APD [D5] -
BioPepDB [D6] -
MBPDB [D7] -
Reference(s)
Primary literature Henschen A, Lottspeich F, Brantl V, Teschemacher H. Novel opioid peptides derived from casein (beta-casomorphins). II. Structure of active components from bovine casein peptone. Hoppe Seylers Z Physiol Chem. 1979 Sep;360(9):1217-24.
PMID: 511111
Other literature(s)

[1] Park Y W. Bioactive Components in Milk and Dairy Products[M]. 2009.
[2] Meisel H, Fitzgerald R J. Opioid peptides encrypted in intact milk protein sequences.[J]. British Journal of Nutrition, 2000, 84(S1):27-31.
[3] Yoshikawa M, Tani F, Yoshimura T, et al. Opioid Peptides from Milk Proteins[J]. Journal of the Agricultural Chemical Society of Japan, 1986, 50(9):2419-2421.
[4] Jarmołowska B, Kostyra E, Krawczuk S, et al. β‐Casomorphin‐7 isolated from Brie cheese[J]. Journal of the Science of Food & Agriculture, 1999, 79(13):1788–1792.
[5] Muehlenkamp M R, Warthesen J J. Beta-casomorphins: analysis in cheese and susceptibility to proteolytic enzymes from Lactococcus lactis ssp. cremoris.[J]. Journal of Dairy Science, 1996, 79(1):20.
[6] Saito T, Nakamura T, Kitazawa H, et al. Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese[J]. Journal of Dairy Science, 2000, 83(7):1434-40.
[7] Brantl V,Teschemacher H,Henschen A et al. Novel opioid peptides derived from casein (beta-casomorphins). I. Isolation from bovine casein peptone.[J] .Hoppe-Seyler's Z. Physiol. Chem., 1979, 360(9): 1211-6.
[8] Lottspeich F, Henschen A, Brantl V, et al. Novel opioid peptides derived from casein (beta-casomorphins). III. Synthetic peptides corresponding to components from bovine casein peptone[J]. Hoppe-Seyler´s Zeitschrift für physiologische Chemie, 1980, 361(2):1835-1840.
[9] Koch G, Wiedemann K, Teschemacher H. Opioid activities of human beta-casomorphins[J]. Naunyn Schmiedebergs Arch Pharmacol, 1985, 331(4):351-354.
[10] Brantl V, Teschemacher H, Blã¤Sig J, et al. Opioid activities of beta-casomorphins[J]. Life Sciences, 1981, 28(17):1903-1909.
[11] Kostyra E, Sienkiewiczszłapka E, Jarmołowska B, et al. Opioid peptides derived from milk proteins.[J]. Polish Journal of Food & Nutrition Sciences, 2004.
[12] Teschemacher H., Schweigerer I., Opioid peptides: do have immunological significance? Trends Pharmacol. Sci., 1985, 6, 368–370.
[13] Nyberg F, Sanderson K, Glämsta E L. The hemorphins: a new class of opioid peptides derived from the blood protein hemoglobin.[J]. Peptide Science, 1997, 43(2):147-156.
[14] Jinsmaa Y, Yoshikawa M. Enzymatic release of neocasomorphin and beta-casomorphin from bovine beta-casein.[J]. Peptides, 1999, 20(8):957.

PubDate 1979
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214